Corona Remedies, a mid-sized pharmaceutical company with strong domestic sales growth, will launch an offer of Rs 655 crore for sale at a price range of Rs 1,008-1,062 per share. The company has a broad portfolio in women’s healthcare, cardio-diabetes and pain management, backed by a pan-India marketing network.Anchor bids are likely to attract a lot of attention given the company’s steady profitability and growing distribution reach.
Furniture and home solutions brand Wakefit Innovations will open its Rs 1,289 crore IPO on the same day, priced at Rs 185-195 per share. Wakefit, known for its first online mattress sale and now a broader portfolio of home products, is one of the closely watched consumer internet lists this month as markets look for signs of continued demand in the durable segment.
Technology-driven document management company Prodocs Solutions will also open its smaller IPO of Rs 27.6 crore on December 8.
The week gets even busier on December 10, when Nephrocare Health Services, Park Medi World and Unisem Agritech launch their three-day issues. Nephrocare, backed by ICICI Securities, plans to raise Rs 871 crore at a price range of Rs 438-460 per share. The dialysis services operator is seen as a play on India’s growing healthcare needs, especially in chronic kidney care, where demand is steadily rising.
Hospital chain Park Medi World will look to raise Rs 920 crore, while Unisem Agritech, a smaller agriculture solutions company, is targeting Rs 21.45 crore. All three will close their subscriptions on December 12.
Rounding out the week are Riddhi Display Equipments, which opened on December 8 and will close on December 10, and two SME releases – Pajson Agro India and Unisem Agritech – releasing on December 11 and 10 respectively. Together, the SME IPOs happening this week will raise around Rs 208 crore.
Investors are also looking forward to the formal announcement of dates for ICICI Prudential AMC’s Rs 10,000 crore initial public offering, one of the largest financial offerings in recent years. The final timing will depend on market conditions, but expect the launch window to fall on December 12.
Analysts say the burst of issuance reflects both issuer confidence and continued market demand for new IPOs, although some warn the supply pipeline is becoming strained just as foreign portfolio investors remain net sellers. Nifty recently touched new all-time highs but gains have been muted, raising concerns about absorption capacity if fundraising continues at this pace.
Still, analysts believe steady domestic liquidity and well-received anchor books should weather most of the mainboard issues, setting up a busy back half of the 2025 IPO calendar.
#IPO #calendar #ICICI #Pru #AMC #Wakefit #anchor #crore #pipeline #week

